- ►annals.org [PDF] RI Berkowitz, K Fujioka, SR Daniels, AG … - Annals of internal medicine, 2006 - Am Coll Physicians Robert I. Berkowitz, MD; Ken Fujioka, MD; Stephen R. Daniels, MD, PhD; Alison G.
Hoppin, MD; Stanford Owen, MD; Arlette C. Perry, PhD; Melinda S. Sothern, PhD;
Cheryl L. Renz, MD; Mark A. Pirner, MD, PhD; Julia K. Walch, BS; Olga ... Cited by 104 - Related articles - BL Direct - All 5 versions
JP Chanoine, S Hampl, C Jensen, M Boldrin, … - Jama, 2005 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context The prevalence of ... Cited by 183 - Related articles - All 14 versions
- ►endojournals.org A Godoy-Matos, L Carraro, A Vieira, J … - Journal of Clinical Endocrinology & Metabolism, 2005 - Endocrine Soc Adolescent obesity is becoming a health problem in both developed and developing
countries. Antiobesity drug therapy is not currently indicated for the treatment
of adolescent obesity and remains investigational at this time. The aim of ... Cited by 97 - Related articles - All 8 versions
D Maahs, DG Serna, RL Kolotkin, S Ralston, … - Endocrine Practice, 2006 - AACE The prevalence of obesity has increased in America and worldwide. Data from 1999
to 2000 indicate that 15.5% of children and adolescents ages 12 to 19 years in
the United States were overweight (defined as body mass index [BMI] >95th ... Cited by 32 - Related articles - BL Direct - All 7 versions
RI Berkowitz, TA Wadden, AM Tershakovec, … - Jama, 2003 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. Cited by 244 - Related articles - BL Direct - All 9 versions
B Ozkan, A Bereket, S Turan, S Keskin - European journal of pediatrics, 2004 - Springer Abstract To investigate the efficacy and tolerability of orlistat in obese
adolescents, a prospective, open-label, randomised, controlled pilot trial was
performed. A total of 22 adolescents with exogeneous obesity were started ... Cited by 33 - Related articles - All 6 versions
- ►endojournals.org S Srinivasan, GR Ambler, LA Baur, SP … - Journal of Clinical Endocrinology & Metabolism, 2006 - Endocrine Soc Context: Metformin therapy for adults and children with type 2 diabetes is well
established. However, its role in the treatment of insulin resistance and
obesity in children and adolescents is less clearly defined. Cited by 63 - Related articles - BL Direct - All 6 versions
S Norgren, P Danielsson, R Jurold, M Lotborn … - Acta Paediatrica, 2003 - interscience.wiley.com Aim: This study investigated orlistat treatment in obese prepubertal children
with regard to tolerance, safety and psychological well-being. Methods: 11
healthy, severely obese prepubertal children (age 8.3–12.3 y, body mass ... Cited by 46 - Related articles - BL Direct - All 6 versions
- ►shouxi.net SR Daniels, B Long, S Crow, D Styne, M … - Pediatrics, 2007 - Am Acad Pediatrics RESULTS. The subjects were randomly assigned to behavioral therapy plus 10 mg of
sibutramine or behavioral therapy plus placebo daily. At the end point, there
was a mean treatment group difference in BMI of 2.6 kg/m 2 in favor of ... Cited by 10 - Related articles - BL Direct - All 8 versions
[CITATION] Del-Rio-Navarro BE, Dorantes-Alvarez LM. Use of sibutramine in obese Mexican adolescents: …
